Randomized, controlled and single center clinical trial of Jifafang in the treatment of acute exacerbation of chronic obstructive pulmonary disease
- Conditions
- acute exacerbation of chronic obstructive pulmonary disease
- Registration Number
- ITMCTR2200005789
- Lead Sponsor
- GuiZhou University of traditiongal Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1.Meet the diagnostic criteria of western medicine for acute exacerbation of chronic obstructive pulmonary disease according to the guidline of GOLD in 2022;
2.Hospitalized patients by emergency department with acute exacerbation within 3 days;
3.with age between 18 and 80 years old;
4.Agree to sign informed consent.
1.Patients who require invasive mechanical ventilation;
2.Complicated with a severe tumor, unstable coronary heart disease, abnormal liver and kidney function, cerebrovascular accident, and other diseases;
3.Those with known or suspected history of alcohol or drug abuse;
4.Patients with mental disorders who are unable to actively cooperate with treatment;
5.Patients with severe intellectual or cognitive impairments;?
6.Patients with a history of allergies to related drugs.?
7.Those who have participated in other clinical trials within the past 3 months;
8.Those who are judged by the investigator to be unsuitable to participate in this clinical trial.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method